Teva Metoprolol Succinate ER 100 mg Recall Expanded for Failed Dissolution Specifications (2026)
Teva Pharmaceuticals recalled 7,448 bottles of Metoprolol Succinate Extended-Release Tablets nationwide after failed dissolution specifications were identified. The recall involves 100 mg, 100‑tablet bottles (NDC 45963-677-11) and 1,000‑tablet bottles (NDC 45963-677-96). The defect may affect drug release and efficacy. Patients should stop using affected bottles and contact Teva or their clinician
Product Details
NDCs: 45963-677-11 (100 mg, 100-tablet bottles) and 45963-677-96 (1000-tablet bottles). Distribution: Nationwide. Quantity: 7,448 bottles. Sold as Rx Only. Brand: METOPROLOL SUCCINATE. Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ 07054.
The Hazard
The product has failed dissolution specifications. The failure can lead to inaccurate release of the active drug, potentially reducing therapeutic effect or causing variable drug levels in patients.
What to Do
1 Stop using the product immediately. 2 Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. 3 Monitor for changes in blood pressure or heart rate and report any concerns to your clinician.
Contact Information
Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054. For guidance, refer to the FDA enforcement report D-0356-2026 and Teva’s recall communications.